7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 
      
    		        
      operating activities
    		        
      net income
    		144,000,000 116,000,000 106,000,000 148,000,000 118,000,000 61,000,000 130,000,000 135,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		        
      depreciation and amortization expense
    		25,000,000 21,000,000 19,000,000 17,000,000 15,000,000 12,000,000 12,000,000 10,000,000 
      stock-based compensation expense
    		81,000,000 106,000,000 66,000,000 86,000,000 69,000,000 136,000,000 9,000,000 142,000,000 
      impairments of long-lived assets and other assets
    		        
      benefit from bad debts
    		3,000,000 5,000,000 4,000,000 3,000,000 4,000,000 4,000,000 8,000,000 5,000,000 
      amortization of operating lease right-of-use assets
    		2,000,000 2,000,000 3,000,000 2,000,000 3,000,000 3,000,000 3,000,000 3,000,000 
      deferred income taxes
    		67,000,000 1,000,000 -2,000,000 4,000,000 28,000,000 -14,000,000 41,000,000 -65,000,000 
      other
    		-11,000,000 1,000,000 6,000,000 2,000,000 0 1,000,000 1,000,000 -1,000,000 
      changes in operating assets and liabilities, net of effects of business acquisitions:
    		        
      accounts receivable
    		-4,000,000 -67,000,000 36,000,000 -73,000,000 -63,000,000 24,000,000 -73,000,000 -16,000,000 
      prepaid expenses and other assets
    		0 18,000,000 28,000,000 -51,000,000 15,000,000 -20,000,000 -2,000,000 -36,000,000 
      accounts payable
    		9,000,000 -9,000,000 -3,000,000 11,000,000 13,000,000 9,000,000 -25,000,000 15,000,000 
      accrued and other current liabilities
    		-49,000,000 10,000,000 22,000,000 24,000,000 -2,000,000 29,000,000 -9,000,000 46,000,000 
      deferred revenue
    		0 1,000,000 17,000,000 -9,000,000 -5,000,000 2,000,000 16,000,000 -4,000,000 
      operating lease liabilities
    		-1,000,000 -3,000,000 -3,000,000 -4,000,000 -5,000,000 -3,000,000 -4,000,000 -4,000,000 
      other long-term liabilities
    		  -1,000,000 -7,000,000 -5,000,000 0 -2,000,000 3,000,000 
      net cash from operating activities
    		287,000,000 203,000,000 298,000,000 153,000,000 185,000,000 244,000,000 105,000,000 233,000,000 
      capex
    		-15,000,000 -16,000,000 -18,000,000 -12,000,000 -14,000,000 -24,000,000 -14,000,000 -16,000,000 
      free cash flows
    		272,000,000 187,000,000 280,000,000 141,000,000 171,000,000 220,000,000 91,000,000 217,000,000 
      investing activities
    		        
      purchases of marketable securities
    		-86,000,000 -82,000,000 -62,000,000 -85,000,000 -20,000,000   -20,000,000 
      maturities of marketable securities
    		94,000,000 46,000,000 81,000,000 16,000,000 10,000,000 16,000,000 28,000,000 27,000,000 
      purchases of property and equipment, including capitalized internal-use software
    		-15,000,000 -16,000,000 -18,000,000 -12,000,000 -14,000,000 -24,000,000 -14,000,000 -16,000,000 
      acquisitions of businesses, net of cash acquired
    		0        
      other investing activities
    		0   0 -2,000,000    
      net cash from investing activities
    		-7,000,000 -157,000,000 1,000,000 -81,000,000   13,000,000  
      financing activities
    		        
      taxes paid related to net share settlement of equity awards
    		-7,000,000 -6,000,000 -8,000,000 -9,000,000 -3,000,000 -6,000,000 -83,000,000 0 
      proceeds from exercise of stock options
    		2,000,000 2,000,000 4,000,000 4,000,000 2,000,000 25,000,000 49,000,000 3,000,000 
      changes in advances from payment card issuer
    		-2,000,000 -4,000,000 47,000,000 -47,000,000     
      repurchases of common stock
    		-62,000,000 -121,000,000 -89,000,000 -5,000,000 -357,000,000 -325,000,000 -715,000,000  
      net cash from financing activities
    		-70,000,000 -129,000,000 -46,000,000 -57,000,000 -301,000,000 -305,000,000 -750,000,000 -36,000,000 
      effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents
    		-1,000,000 4,000,000 1,000,000 -7,000,000 2,000,000 -2,000,000 -4,000,000  
      net increase in cash, cash equivalents, and restricted cash and cash equivalents
    		208,000,000 -78,000,000 254,000,000 8,000,000 -140,000,000 -76,000,000 -636,000,000 189,000,000 
      cash, cash equivalents, and restricted cash and cash equivalents - beginning of period
    		0 0 1,449,000,000 0 0 0 2,293,000,000 0 
      cash, cash equivalents, and restricted cash and cash equivalents - end of period
    		208,000,000 -78,000,000 1,703,000,000 8,000,000 -140,000,000 -76,000,000 1,657,000,000 189,000,000 
      other financing activities
    		      -1,000,000  
      proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts
    		       0 
      proceeds from the issuance of series a redeemable convertible preferred stock
    		        
      proceeds from exercise of common stock warrants
    		        
      proceeds from modification of common stock warrants
    		        
      deferred offering costs paid
    		       -3,000,000 
      purchases of patents
    		      -1,000,000  
      amortization of common stock warrants
    		        
      amortization and remeasurement of common stock issuable pursuant to subscription agreement
    		        
      net cash provided (used in) by investing activities
    		        
      proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs
    		        
      proceeds from the issuance of non-voting common stock
    		        
      proceeds from issuance of series a redeemable convertible preferred stock
    		        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.